Target intelligence / Profile preview

Immunoglobulin lambda variable 2-34 (IGLV2-34)

Target
IGLV2-34
Molecular classification
Other, Pseudogene, Immunoglobulin gene segment
01

Overview

Immunoglobulin lambda variable 2-34 (IGLV2-34) is a gene segment in the immunoglobulin lambda locus, annotated as a pseudogene[1][5]. This means it does not produce a functional protein and is not directly involved in immunological or pathological processes. While immunoglobulin variable regions are critical for antigen recognition, IGLV2-34 itself does not participate due to lack of biological activity or expression. It is not considered a therapeutic target, receptor, enzyme, or transporter. Summary of key points: - IGLV2-34 is a non-coding pseudogene in the immunoglobulin lambda light chain locus[1][5]. - Not a receptor, enzyme, or recognized therapeutic target. - No known drugs, biomarkers, or disease roles are associated with this pseudogene. - Curation errors may occur if IGLV2-34 is treated as a functional target; it should not be included as a canonical therapeutic target. If you require information about functional immunoglobulin lambda variable regions, those would be the genes that encode active protein segments contributing to antibody diversity[3][5].

Other names
Immunoglobulin lambda variable 2-34 (pseudogene)

Beyond the preview

Go deeper on Immunoglobulin lambda variable 2-34 (IGLV2-34).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin lambda variable 2-34 (IGLV2-34).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call